摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Quinolin-3(4h)-one | 655239-54-6

中文名称
——
中文别名
——
英文名称
Quinolin-3(4h)-one
英文别名
4H-quinolin-3-one
Quinolin-3(4h)-one化学式
CAS
655239-54-6
化学式
C9H7NO
mdl
——
分子量
145.16
InChiKey
GRRBXRZINPHFGD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    297.8±43.0 °C(Predicted)
  • 密度:
    1.18±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    29.4
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • [EN] PYRAZOLOPYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRAZOLOPYRIDINE POUR LE TRAITEMENT DU CANCER
    申请人:GENENTECH INC
    公开号:WO2017205538A1
    公开(公告)日:2017-11-30
    The present invention relates to a compound formula (I): and to salts thereof, wherein R1, R2X, and Y have any of the values defined herein, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders such as cancer, inflammatory disorders and autoimmune diseases.
    本发明涉及一种化合物公式(I)及其盐,其中R1、R2X和Y具有本文中定义的任何值,以及其组合物和用途。这些化合物可用作CBP和/或EP300的抑制剂。还包括包含公式(I)化合物或其药学上可接受的盐的药物组合物,以及在治疗各种CBP和/或EP300介导的疾病,如癌症、炎症性疾病和自身免疫疾病中使用这些化合物和盐的方法。
  • [EN] PIPERAZINE- SUBSTITUTED BENZOTHIOPHENE DERIVATIVES AS ANTIPSYCHOTIC AGENTS<br/>[FR] DÉRIVÉS DE BENZOTHIOPHÈNE SUBSTITUÉ PAR PIPÉRAZINE EN TANT QU'AGENTS ANTIPSYCHOTIQUES
    申请人:OTSUKA PHARMA CO LTD
    公开号:WO2013035892A1
    公开(公告)日:2013-03-14
    Provided is a superior, novel heterocyclic compound with improved solubility in oil such as sesame oil and benzyl benzoate, which has a broader treatment spectrum, causes less side effects, and is superior in tolerability and safety, and use thereof. A heterocyclic compound represented by the formula (I) wherein each symbol is as defined in the specification, or a salt thereof.
    提供了一种优越的、新颖的杂环化合物,其在油中的溶解性得到改善,如芝麻油和苯基苯甲酸酯,具有更广泛的治疗范围,引起的副作用更少,在耐受性和安全性方面更为优越,以及其使用。表示为式(I)的杂环化合物,其中每个符号如规范中定义的,或其盐。
  • [EN] C-7 ISOXAZOLINYL QUINOLONE/NAPHTHYRIDINE DERIVATIVES USEFUL AS ANTIBACTERIAL AGENTS<br/>[FR] DÉRIVÉS DE C-7 ISOXAZOLINYL QUINOLONE/NAPHTHYRIDINE CONVENANT COMME AGENTS ANTI-BACTÉRIENS
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2010093341A1
    公开(公告)日:2010-08-19
    The present invention relates to C-7 isoxazolyl quinoline/naphthyridine derivatives useful as antimicrobial compounds, pharmaceutical compositions comprising said derivatives and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.
    本发明涉及C-7异噁唑喹啉/啶衍生物,可用作抗微生物化合物,包括含有这些衍生物的药物组合物以及将这些衍生物和药物组合物用作抗病原微生物的抗微生物剂,特别是对抗耐药菌。
  • C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents
    申请人:Macielag Mark J.
    公开号:US20090029980A1
    公开(公告)日:2009-01-29
    The present invention relates to C-7 isoxazolyl quinoline/naphthyridine derivatives useful as antimicrobial compounds, pharmaceutical compositions comprising said derivatives and the use of said derivatives and pharmaceutical compositions as antimicrobial agents against pathogenic microorganisms, particularly against resistant microbes.
    本发明涉及C-7异噁唑喹啉/啶衍生物,可用作抗微生物化合物,包括含有该衍生物的药物组合物以及将该衍生物和药物组合物用作抗病原微生物的抗微生物剂,特别是对抗耐药微生物
  • Inhibitors of the Human Aldosterone Sythase CYP11B2
    申请人:Hartmann Rolf W.
    公开号:US20110112067A1
    公开(公告)日:2011-05-12
    The invention provides compounds of the general formula (I) which are inhibitors of the human aldosterone synthase, and also pharmaceutical compositions containing these compounds, and a method of treating of hyperaldosteronism and/or disorders or diseases that are mediated by 11β-hydroxylase (CYP11B1) with these compounds.
    该发明提供了一般式(I)的化合物,这些化合物是人类醛固酮合成酶的抑制剂,还包括含有这些化合物的药物组合物,以及使用这些化合物治疗高醛固酮症和/或由11β-羟化酶(CYP11B1)介导的疾病或疾病的方法。
查看更多